GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Healthcare Investors (NYSE:HQH) » Definitions » Revenue
中文

abrdn Healthcare Investors (abrdn Healthcare Investors) Revenue : $58.12 Mil (TTM As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is abrdn Healthcare Investors Revenue?

abrdn Healthcare Investors's revenue for the six months ended in Sep. 2023 was $-25.97 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $58.12 Mil. abrdn Healthcare Investors's Revenue per Share for the six months ended in Sep. 2023 was $-0.48. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.24.

Warning Sign:

abrdn Healthcare Investors revenue per share has been in decline over the past 3 years.

During the past 3 years, the average Revenue per Share Growth Rate was -41.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 7 years, abrdn Healthcare Investors's highest 3-Year average Revenue per Share Growth Rate was 31.10% per year. The lowest was -41.00% per year. And the median was 7.60% per year.


abrdn Healthcare Investors Revenue Historical Data

The historical data trend for abrdn Healthcare Investors's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Healthcare Investors Revenue Chart

abrdn Healthcare Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Revenue
Get a 7-Day Free Trial -143.63 242.92 157.10 -192.27 58.12

abrdn Healthcare Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.61 -114.09 -78.18 84.09 -25.97

Competitive Comparison of abrdn Healthcare Investors's Revenue

For the Asset Management subindustry, abrdn Healthcare Investors's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Healthcare Investors's Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's Revenue distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's Revenue falls into.



abrdn Healthcare Investors Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $58.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


abrdn Healthcare Investors  (NYSE:HQH) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


abrdn Healthcare Investors Revenue Related Terms

Thank you for viewing the detailed overview of abrdn Healthcare Investors's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


abrdn Healthcare Investors (abrdn Healthcare Investors) Business Description

Traded in Other Exchanges
N/A
Address
900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
Executives
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022

abrdn Healthcare Investors (abrdn Healthcare Investors) Headlines

From GuruFocus

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 08-17-2021

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 02-15-2022

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 05-15-2023

Tekla Healthcare Investors Paid Distribution

By Business Wire 06-30-2023

Tekla Healthcare Investors Declares Stock Distribution

By Business Wire Business Wire 05-18-2021

Tekla Healthcare Investors Declares Distribution

By Business Wire Business Wire 08-16-2022